Cargando…
Safety and Feasibility of Repeated Intrathecal Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells in Patients with Neurological Diseases
Mesenchymal stromal cells (MSCs) have become the most commonly used adult stem cells in regenerative medicine. Preclinical studies have shown that MSCs-based therapy is a potential new treatment approach for neurological diseases. Intrathecal injection has unique feature which allows stem cells to d...
Autores principales: | Pan, Kuang, Deng, Lingna, Chen, Peiying, Peng, Qingxia, Pan, Jingrui, Wu, Yanfeng, Wang, Yidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683773/ https://www.ncbi.nlm.nih.gov/pubmed/31428161 http://dx.doi.org/10.1155/2019/8421281 |
Ejemplares similares
-
Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs
por: Benavides, Felipe Pérez, et al.
Publicado: (2021) -
Feasibility and safety of intrathecal transplantation of autologous bone marrow mesenchymal stem cells in horses
por: Maia, Leandro, et al.
Publicado: (2015) -
Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo
por: Pezzanite, Lynn M, et al.
Publicado: (2015) -
Immune response treated with bone marrow mesenchymal stromal cells after stroke
por: Wang, Zili, et al.
Publicado: (2022) -
Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
por: Oh, Ki‐Wook, et al.
Publicado: (2018)